In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia
- 30 September 2009
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 113 (2-3), 322-331
- https://doi.org/10.1016/j.schres.2009.06.014
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- Temporal lobe volume in bipolar disorder: Relationship with diagnosis and antipsychotic medication useJournal of Affective Disorders, 2009
- Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different TreatmentsCerebral Cortex, 2008
- Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1Schizophrenia Research, 2008
- Molecular profiles of schizophrenia in the CNS at different stages of illnessBrain Research, 2008
- Effect of Chronic Antipsychotic Exposure on Astrocyte and Oligodendrocyte Numbers in Macaque MonkeysBiological Psychiatry, 2007
- Differential effects of typical and atypical antipsychotics on brain myelination in schizophreniaSchizophrenia Research, 2007
- Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disordersProceedings of the National Academy of Sciences, 2007
- Decreased levels of apolipoprotein A-I in plasma of schizophrenic patientsJournal of Neural Transmission, 2006
- Reduced Intracortical Myelination in SchizophreniaAmerican Journal of Psychiatry, 2005
- Association of Genetic Risks for Schizophrenia and Bipolar DisorderWith Specific and Generic Brain Structural EndophenotypesArchives of General Psychiatry, 2004